Page 9 - MEMOCiberesp014-ENG
P. 9
ORGANIZATIONAL STRUCTURE
In 2014, CIBER-BBN, along with other CIBERs of the same nature, has been integrated in a common struc- ture, with a single legal entity and under the legal status of a consortium formed by 90 institutions . Since 2014, CIBER-BBN continues to maintain its independence in terms of scientific management, although it constitutes a subject area within CIBER, a unique research structure in Spain in the field of biomedical re- search with great scientific potential .
The maximum decision-making body of CIBER is the Governing Board formed by 3 representatives from the ISCIII and 1 institutional representative from each of the Consortium Institutions . It is chaired by the Direc- tor of the ISCIII and meets on a half-yearly basis . The Permanent Commission is an appointed commission (formed by the ISCIII and 8 members of the Governing Board that are renewed every 6 months) that meets more often to make those decisions which, given their nature, cannot wait to be approved by the Governing
Board, more swiftly .
Within the subject area of BBN (Bioengineering, Biomaterials and Nanomedicine), the basic and functional units are made up of 46 research groups (44 full member groups and 2 associated groups in 2014) descri- bed in detail in this report .
From the scientific point of view, the organisational structure is based on the member research groups, Research Programmes and Horizontal Programmes, with a coordinator for each Programme that is a Stee- ring Committee member . Scientific decisions are made by the Scientific Director, counseled by the Steering Committee and the Scientific Advisory Board .
The Steering Committee, chaired by the Scientific Director comprises programme coordinators and the Managing Director .
STEERING COMMITEE 2014
The members that are part of CIBER-BBN Scientific Advisory Board are ten renowned scientists from the disciplines that the Centre works in . There are two researchers in the Bioengineering Programme, three in the Biomaterials and Nanomedicine Programmes, and two in the Horizontal Programmes .
Position
Name
Scientific Director
Pablo Laguna Lasaosa
Assistant Scientific Director and Industrial Transfer Coordinator
Simó Schwartz Navarro
Bioengineering Programme Coordinator
Jordi Aguiló Llobet
Biomaterials Programme Coordinator
José Luis Becerra Ratia
Nanomedicine Programme Coordinator
Ma Pilar Marco Colás
Clinical Translation Coordinator
Margarita Calonge Cano
Platform Programme Coordinator
Jesús Santamaría Ramiro
Training Programme Coordinator
Javier Pavía Segura
Managing Director
Manuel Sánchez Delgado
Scientific Director Assistant
Begoña Pérez Magallón
www .ciber-bbn .es	9


































































































   7   8   9   10   11